Patents by Inventor Weimin Zhu

Weimin Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11959804
    Abstract: The invention provides a curved-slit imaging spectrometer, wherein a fiber bundle transfers a straight line image of a front objective lens to a curved slit, and the front objective lens doesn't need to have a curved image plane to directly abut the spectrometer, so that the system is less complicated, and the front objective lens and spectrometer have a simple structure. The arc-shaped or approximately arc-shaped curved slit matches the optimum imaging circle of the Offner-type spectrometer, thereby achieving an extra-long slit. The arced slit is 5 to 10 times longer than the straight slit of the classical Offner-type spectrometer. In the case of a compact size, the length of the slit can be greater than 100 mm. Also, the same spectral response function applies in different fields of view while presenting desirable imaging quality.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: April 16, 2024
    Assignee: SOOCHOW UNIVERSITY
    Inventors: Jiacheng Zhu, Qiao Pan, Xinhua Chen, Weimin Shen
  • Publication number: 20230406948
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Application
    Filed: March 13, 2023
    Publication date: December 21, 2023
    Inventors: Yongke ZHANG, Guo-Liang YU, Weimin ZHU
  • Patent number: 11712066
    Abstract: A measurement circuit and a measurement method for measuring and updating a voltage resolution of an electronic atomizer circuit are provided. In the measurement circuit, a comparison unit is configured to compare a first preset value and a second preset value to obtain a voltage difference, an accumulation and subtraction unit is configured to perform counting according to a comparison result, and a control unit is configured to adjust the voltage difference between two compared voltage input terminals, thereby calculating a voltage resolution of the control unit, avoiding the impact of the actual error of the first constant current source and the unit resistor on the actual voltage resolution, and ensuring the measurement accuracy. In addition, an accurate to-be-measured voltage is calculated, and a measurement value of the to-be-measured voltage is corrected, to ensure the high measurement accuracy of the to-be-measured voltage and the output power.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: August 1, 2023
    Assignee: WUXI CRYSTAL SOURCE MICRO ELECTRONICS CO., LTD.
    Inventors: Weimin Zhu, Zheng Jiang, Hua Shen
  • Publication number: 20230002757
    Abstract: A method for generating a plurality of diverse camelid antibodies to cover functional epitopes of the target with high-resolution. Also provided is a method for generating camelid antibodies.
    Type: Application
    Filed: August 28, 2020
    Publication date: January 5, 2023
    Inventor: Weimin Zhu
  • Publication number: 20220408837
    Abstract: The present invention provides a measurement circuit and a measurement method. In the measurement circuit, a comparison unit is configured to compare a first preset value and a second preset value to obtain a voltage difference, an accumulation and subtraction unit is configured to perform counting according to a comparison result, and a control unit is configured to adjust the voltage difference between two compared voltage input terminals, thereby calculating a voltage resolution of the control unit, avoiding the impact of the actual error of the first constant current source and the unit resistor on the actual voltage resolution, and ensuring the measurement accuracy. In addition, an accurate to-be-measured voltage is calculated, and a measurement value of the to-be-measured voltage is corrected, to ensure the high measurement accuracy of the to-be-measured voltage and the output power.
    Type: Application
    Filed: August 26, 2022
    Publication date: December 29, 2022
    Applicant: WUXI CRYSTAL SOURCE MICRO ELECTRONICS CO.,LTD.
    Inventors: Weimin Zhu, Zheng Jiang, Hua Shen
  • Publication number: 20220049005
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Application
    Filed: April 7, 2021
    Publication date: February 17, 2022
    Inventors: Yongke ZHANG, Guo-Liang YU, Weimin ZHU
  • Publication number: 20220049006
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Application
    Filed: April 15, 2021
    Publication date: February 17, 2022
    Inventors: Yongke ZHANG, Guo-Liang YU, Weimin ZHU
  • Patent number: 11007106
    Abstract: Disclosed is a postoperative functional exerciser for frozen shoulder. The exerciser includes a hand push rod (1) and a restrictive band (2) for restricting the elbow. The hand push rod (1) comprises a wristband (11) and a push rod (12). One end of the push rod (12) is connected with the wristband (11). When the hand push rod (1) and the restrictive band (2) are in operation, a part of the restrictive band (2) winds around the elbow joint of an affected arm, the other part winds around a waist buckle (3) at a waist portion of the restrictive band (2) on a side opposite to the affected arm, and the wristband (11) is sleeved on the wrist of the affected arm. The upper arm is tied to the body by means of the restrictive band (2).
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: May 18, 2021
    Assignee: SHENZHEN SECOND PEOPLE'S HOSPITAL
    Inventors: Weimin Zhu, Daping Wang, Jianyi Xiong, Wei Lu, Jiaming Cui, Kang Chen, Liangquan Peng
  • Patent number: 11001637
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: May 11, 2021
    Assignee: Apexigen, Inc.
    Inventors: Yongke Zhang, Guo-Liang Yu, Weimin Zhu
  • Patent number: 10934524
    Abstract: Provided herein, inter alia, is a method for producing an enriched population of antigen-specific plasma cells. In some embodiments, the method may comprise: (a) obtaining a sample of cells from an animal that has been immunized by an antigen, wherein the sample comprises B cells; (b) enriching for a population of antigen-specific B cells that comprise cell surface antibodies that are specific for the antigen by: i. contacting at least 105 of the cells in said sample, en masse, with the antigen or a portion thereof; and ii. isolating cells that bind to the antigen or portion thereof; and (c) activating the enriched B cells, en masse, in the presence of the antigen or portion thereof, to produce the enriched population of antigen-specific plasma cells.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: March 2, 2021
    Assignee: EPITOMICS, INC.
    Inventors: Luc Adam, Karin Vroom, Liang Xiang, Li Wei, Weimin Zhu
  • Publication number: 20190309080
    Abstract: The present invention provides anti-RANKL monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of rheumatoid arthritis and other diseases.
    Type: Application
    Filed: February 27, 2019
    Publication date: October 10, 2019
    Inventors: Yongke Zhang, Xiaodong Yang, Guo-Liang Yu, Weimin Zhu
  • Patent number: 10377814
    Abstract: The invention provides a rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody. The immortal B-lymphocyte does not detectably express endogenous immunoglobulin heavy chain and may contain, in certain embodiments, an altered immunoglobulin heavy chain-encoding gene. A hybridoma resulting from fusion between the subject immortal B-lymphocyte and a rabbit antibody-producing cell is provided, as is a method of using that hybridoma to produce an antibody. The subject invention finds use in a variety of different diagnostic, therapeutic and research applications.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: August 13, 2019
    Assignee: EPITOMICS, INC.
    Inventors: Robert Pytela, Weimin Zhu, Yaohuang Ke, Qi Qian, Harry C. Au
  • Patent number: 10259878
    Abstract: The present invention provides anti-RANKL monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of rheumatoid arthritis and other diseases.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: April 16, 2019
    Assignee: APEXIGEN, INC.
    Inventors: Yongke Zhang, Xiaodong Yang, Guo-Liang Yu, Weimin Zhu
  • Publication number: 20180369055
    Abstract: Disclosed is a postoperative functional exerciser for frozen shoulder. The exerciser includes a hand push rod (1) and a restrictive band (2) for restricting the elbow. The hand push rod (1) comprises a wristband (11) and a push rod (12). One end of the push rod (12) is connected with the wristband (11). When the hand push rod (1) and the restrictive band (2) are in operation, a part of the restrictive band (2) winds around the elbow joint of an affected arm, the other part winds around a waist buckle (3) at a waist portion of the restrictive band (2) on a side opposite to the affected arm, and the wristband (11) is sleeved on the wrist of the affected arm. The upper arm is tied to the body by means of the restrictive band (2).
    Type: Application
    Filed: August 31, 2018
    Publication date: December 27, 2018
    Inventors: Weimin ZHU, Daping WANG, Jianyi XIONG, Wei LU, Jiaming CUI, Kang CHEN, Liangquan PENG
  • Publication number: 20180273630
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Application
    Filed: March 13, 2018
    Publication date: September 27, 2018
    Inventors: Yongke ZHANG, Guo-Liang Yu, Weimin Zhu
  • Publication number: 20180201900
    Abstract: Provided herein, inter alia, is a method for producing an enriched population of antigen-specific plasma cells. In some embodiments, the method may comprise: (a) obtaining a sample of cells from an animal that has been immunized by an antigen, wherein the sample comprises B cells; (b) enriching for a population of antigen-specific B cells that comprise cell surface antibodies that are specific for the antigen by: i. contacting at least 105 of the cells in said sample, en masse, with the antigen or a portion thereof; and ii. isolating cells that bind to the antigen or portion thereof; and (c) activating the enriched B cells, en masse, in the presence of the antigen or portion thereof, to produce the enriched population of antigen-specific plasma cells.
    Type: Application
    Filed: March 11, 2016
    Publication date: July 19, 2018
    Inventors: Luc Adam, Karin Vroom, Liang Xiang, Li Wei, Weimin Zhu
  • Patent number: 9994640
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: June 12, 2018
    Assignee: Apexigen, Inc.
    Inventors: Yongke Zhang, Guo-Liang Yu, Weimin Zhu
  • Publication number: 20170246297
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Application
    Filed: May 12, 2017
    Publication date: August 31, 2017
    Inventors: Yongke Zhang, Guo-Liang Yu, Weimin Zhu
  • Publication number: 20170233483
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Application
    Filed: December 19, 2016
    Publication date: August 17, 2017
    Inventors: Yongke ZHANG, Guo-Liang YU, Weimin ZHU
  • Patent number: 9676861
    Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: June 13, 2017
    Assignee: Apexigen, Inc.
    Inventors: Yongke Zhang, Guo-Liang Yu, Weimin Zhu